Blogs

CU Cancer Center News and Stories

Animal

Research    Cancer    Funding    Animal

Four Collaborative Human/Canine Cancer Research Projects Receive Pilot Grant Funding

Four research projects conducted by University of Colorado Cancer Center members from the University of Colorado Anschutz Medical Campus and Colorado State University recently each received $50,000 pilot grant funding from the Joint Pilot Program of the CU Cancer Center and CSU Flint Animal Cancer Center.


Author Rachel Sauer | Publish Date May 26, 2022
Full Story

Research    Cancer    Animal

How human genetic data could help dogs fight cancer

Some of what we learn through the compassionate treatment of dogs with cancer goes on to help human patients. Now a study by researchers at University of Colorado Cancer Center and Colorado State University Flint Animal Cancer Center returns the favor: We know so many of the genetic changes that cause human cancer – the current study, recently published in the journal Molecular Cancer Therapeutics, sequences 33 canine cancer cell lines to identify “human” genetic changes could be driving these canine cancers, possibly helping veterinary oncologists use more human medicines to cure cancer in dogs.


Author Cancer Center | Publish Date June 25, 2019
Full Story

CU Cancer Center In the News

Targeted Oncology

Forsberg Explains How Selinexor Fits Into Sequencing Therapies in R/R Multiple Myeloma

news outletTargeted Oncology
Publish DateNovember 16, 2022

During a roundtable event, Peter Forsberg, MD, discussed data from several trials of selinexor in patients with relapsed/refractory multiple myeloma.

Full Story
Cancer Health

Pancreatic Cancer Survivor Shares a Message of Hope

news outletCancer Health
Publish DateNovember 15, 2022

November is Pancreatic Cancer Awareness Month. Laura Foote shares her story to bring hope and express gratitude.

Full Story
TIME

How Bladder Cancer Differs in Women and Younger Adults

news outletTIME
Publish DateNovember 15, 2022

Men are three to four times more likely than women to develop bladder cancer, but the disease tends to be deadlier in females. Why?

Full Story
Biospace

Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers

news outletBiospace
Publish DateNovember 14, 2022

New therapeutic addresses need in patients suffering with cold and refractory tumors.

Full Story